Istinye University Topkapi Campus
Zeytinburnu
Istanbul
Turkey
Istinye University
Ovarian function suppression, HER2 positive, adjuvant endocrine therapy, aromatase inhibitors, tamoxifen, LHRH agonists, neoadjuvant, residual disease, pathological complete response